Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: therapy + 0.18 + web  Related to the article below (Last Update: 8/5/2008)

Panacos Reports Second Quarter 2008 Financial Results
Genetic Engineering News (press release), NY - Jul 30, 2008
Resistance to currently available drugs is one of the most pressing problems in HIV therapy and the leading cause of treatment failure. ...PANC
Source: Google News

Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly … -
DG Seeley, JA Cauley, D Grady, WS Browner, MC … - Archives of Internal Medicine, 1995 - Am Med Assoc
... browser does not support basic Web standards ... Is postmenopausal estrogen therapy
associated with neuromuscular function ... strength (0.005 kg; -0.17 to 0.18 kg), or ...

WEB BASED LEARNING MODULES FOR INTERVENTIONAL PULMONARY PROCEDURES: LASER THERAPY AND STENT …
P NGUYEN, P ROBINSON, H COLT, M CHIA, M HOLMES, H … - Respirology, 2007 - pt.wkhealth.com
... others and to determine patient?s perceptions of long term oxygen therapy as a ... tutorials
and competency assessments that are accessible via the web at anytime ...

… of Patient Morbidity, Operation Strategy, and Perioperative Antiplatelet/Anticoagulation Therapy -
UKH Wiegand, D LeJeune, F Boguschewski, H … - Chest, 2004 - Am Coll Chest Phys
... between patients with atrial fibrillation receiving high-dose or low-dose
heparinization before receiving effective oral anticoagulation therapy (0.18% vs ...

Duration of the survival benefit of zidovudine therapy in HIV infection -
RD Moore, JC Keruly, RE Chaisson - Archives of Internal Medicine, 1996 - Am Med Assoc
... Web browser does not support basic Web standards ... dying during the first year of therapy
(relative hazard ... death, 0.32; 95% confidence interval [CI], 0.18 to 0.59 ...

Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant … -
J Ragaz, IA Olivotto, JJ Spinelli, N Phillips, SM … - jnci, 2005 - jnci.oxfordjournals.org
... was 74% for patients assigned to chemotherapy alone and was 90% for those assigned
to chemotherapy and radiation therapy (RR = 0.36, 95% CI = 0.18 to 0.71; P ...

… of the Clinical and Histological Effectiveness of Isotretinoin in the Therapy of Oral Leukoplakia … -
GA Scardina, F Carini, E Maresi, V Valenza, P … - development - journals.prous.com
... Available on the web at: www.prous.com/journals ... 1. Clinical features before (A)
and after (B) therapy (isotretinoin 0.18%) (magnification: ?25 ...

… -vessel panarteritis mimicking deep sepsis following etanercept and minocycline therapy in a patient … -
JM Berthelot, J Glemarec, Y Maugars, A Prost - Rheumatology, 2002 - Br Soc Rheumatology
... panarteritis mimicking deep sepsis following etanercept and minocycline therapy
in a ... Creatine phosphokinase was normal in each test (0.18 mkat; normal range 0.0 ...

A Tale of Two Futures: HIV and Antiretroviral Therapy in San Francisco -
SM Blower, HB Gershengorn, RM Grant - Science, 2000 - sciencemag.org
... browser that does not support current Web standards ... resistant strains are less
responsive to therapy (6), we ... sensitive, treated infection ( S T ), 0.18, 0.65, 0.84 ...

Who Benefits from Brief Psychodynamic Therapy for Generalized Anxiety Disorder?
P Crits-Christoph, MBC Gibbons, D Losardo, J … - Canadian Journal of Psychoanalysis, 2004 - PEP Web
... personal use of the subscriber to PEP Web and is ... Any Axis II disorder, 0.15, 0.19,
0.18. ... about therapy/medication and interpersonal variables as predictors and to ...
-

Gender Moderates the Effects of Exercise Therapy on Health-Related Quality of Life Among COPD … -
CG Foy, WJ Rejeski, MJ Berry, D Zaccaro, CM … - Chest, 2001 - Am Coll Chest Phys
... Search for citing articles in: ISI Web of Science (1). ... sizes that were considered
small (0.18 for emotional ... that 3 months of exercise therapy has differential ...

Source: Google Scholar

Estrogen-Plus-Testosterone Therapy Increases Breast Cancer Risk

Women who take the hormones estrogen and testosterone in tandem to treat symptoms of menopause appear to have an increased risk of breast cancer, researchers report.

The finding are published in the July 24 issue of the Archives of Internal Medicine.

Another report in the same journal issue finds that alternative therapies to hormone replacement therapy (HRT) don't seem to work.

In the first report, Rulla M. Tamimi, of Brigham and Women's Hospital in Boston and Harvard Medical School, and her colleagues collected data on 121,700 women, who were part of the Nurses' Health Study. The researchers looked at the long-term effects of estrogen-plus-testosterone therapy.

"Estrogen plus testosterone increases the risk of breast cancer," Tamimi said. "There needs to be other studies to support these findings, but there does seem to be an increased risk, and women and their physicians should weigh the risks and benefits of estrogen-plus-testosterone therapy before starting," she said.

There is some evidence that many of the symptoms of menopause --including decreased sex drive, mood swings and poorer quality of life, such as hot flashes, night sweats, vaginal dryness and sleep problems -- are related to this decline in testosterone, the authors noted. Previous clinical trials had shown that testosterone in combination with estrogen may reduce these symptoms and promote bone health.

The increased breast cancer risk associated with testosterone may be because enzymes in breast tissue convert testosterone to estradiol, an estrogen-like hormone that could contribute to the development of breast cancer, the authors said. Higher levels of testosterone alone have also been linked to increased breast-cancer risk in postmenopausal women.

Currently in the United States, there is only one estrogen-plus-testosterone therapy available, but such treatments are expected to increase in coming years, according to the report.

During 24 years of follow-up for the study, there were 4,610 cases of breast cancer. The 29 women who were taking estrogen plus testosterone had a 77 percent higher risk of developing breast cancer than those who never used hormone therapy, the researchers reported.

The risk associated with this combination therapy was higher than the risk associated with estrogen therapy (15 percent) and of estrogen-plus-progestin therapy (58 percent), Tamimi said.

Looking only at women who had gone through menopause naturally rather than those who had had a hysterectomy, Tamimi's group found that the 17 women who took estrogen plus testosterone had 2.5 times the risk of breast cancer compared with those who had never used hormones.

One expert doesn't think that, in most cases, testosterone should be prescribed for women.

"We have always been careful about prescribing testosterone to women, based on unknown risks," said Dr. Hugh Taylor, an associate professor of obstetrics and gynecology at Yale University School of Medicine. Testosterone doesn't appear to offer a benefit much beyond a placebo effect, he added.

"We have always been hesitant about using it, and this re-enforces it," Taylor said. "The usual reason women request testosterone is for decreased libido. But for most women, decreased libido is not due to decreased testosterone. It's due to a myriad of other problems."

Concerns about hormone-replacement therapy were first raised in 2002 by the Women's Health Initiative, the landmark study involving 27,000 participants that caused many women to discontinue their use of hormone therapy.

In the second study in the journal, researchers who reviewed 70 previous studies of alternative and complementary therapies for menopause-related symptoms found there was insufficient evidence that these therapies relieve menopause-related symptoms.

"There is a significant placebo effect in almost anything that is used for the management of menopause," said study lead researcher Dr. Anne Nedrow, of the Oregon Evidence-based Practice Center and Oregon Health and Science University. "There is a lack of any evidence that of the millions and millions of dollars spent on alternative therapies that anything really works.

Nedrow's group looked at 48 studies that examined vitamins, proteins, complete diets or other biologically based treatments; nine studies that focused on mind-body therapies, including meditation and guided imagery; one study of osteopathic manipulation, a body-based therapy; two that looked at the energy-based treatments reflexology and magnet therapy; and 10 that assessed whole medical systems, such as traditional Chinese medicine or ayurvedic medicine, a traditional therapy from India.

Nedrow said the study found there really aren't any good alternative or complementary choices for women going through menopause. "The truly symptomatic women may need to reconsider estrogen," she said. "Or we may want to take advantage of the placebo effect, which has shown a 50 percent reduction in symptoms in 12 weeks," she added.

Nedrow said she doesn't think there's any harm in using alternative therapies. She recommended black cohosh or soy supplements, with the understanding that most of the effect would be a placebo effect.

One expert agreed that the benefit of alternative therapy to relieve menopausal symptoms is largely a placebo effect.

"Currently, the best medication we have to remove menopausal symptoms is estrogen," said Dr. Jennifer Wu, an obstetrician/gynecologist at Lenox Hill Hospital, in New York City. But, she added, "The associated risks make it less than desirable."

More information

 

 

 

 

 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.